Jupiter Life Line Hospitals Ltd

Jupiter Life Lin Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Jupiter Life Line Hospitals Ltd

₹ 1,422 0.78%
21 May 2:21 p.m.
jupiterhospital.com BSE: 543980 NSE: JLHL
About

Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]

Key Points

Hospital Portfolio[1]
1. Locations and Bed Capacity
- Thane: Operational since 2007, 377 beds, average occupancy rate of 72.0%, and ARPOB (Average Revenue Per Occupied Bed) of ₹66,700.
- Pune: Operational since 2017, 375 beds, average occupancy rate of 67.0%, and ARPOB of ₹55,000.
- Indore: Operational since 2020, 231 beds, average occupancy rate of 59.0%, and ARPOB of ₹44,700.

New Developments[2]
- Added 22 beds in Pune in Q2 FY25.
- 75 additional beds are under development at the Indore hospital, expected by Q4 FY25.
- Construction of the Dombivli hospital is on track, and regulatory approvals are being finalized for a second unit in Pune. These expansions will raise the total bed capacity to ~2,500 beds.

Capex[3]
1) CWIP grew from 74 Crs in March 2024 to 135.1 Crs in September 2024, reflecting ongoing expansion projects.
2) The company spent 165.3 Crs on investments during H1 FY25.

Key Operating Metrics - H1FY25[4]
- Operational Beds: 851 beds.
- Occupancy Rate: 67.2%
- Patient Volume: Grew from 53,100 to 57,700.
- ALOS (Average Length of Stay): Slightly decreased to 3.85 days from 3.89 days.

Website BSE NSE
  • Market Cap ₹ 9,324 Cr.
  • Current Price ₹ 1,422
  • High / Low ₹ 1,770 / 1,068
  • Stock P/E 48.3
  • Book Value ₹ 207
  • Dividend Yield 0.07 %
  • ROCE 18.4 %
  • ROE 15.3 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 44.3% CAGR over last 5 years

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Part of BSE Healthcare BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
201 221 228 242 243 263 273 291 287 323 322 327
151 166 183 191 190 202 211 228 223 248 246 248
Operating Profit 49 55 45 52 53 61 62 63 64 75 76 78
OPM % 25% 25% 20% 21% 22% 23% 23% 22% 22% 23% 24% 24%
2 3 2 1 4 3 8 10 8 9 7 7
Interest 10 10 11 11 12 12 1 1 1 1 3 6
Depreciation 9 10 10 10 11 11 11 10 11 14 14 18
Profit before tax 32 38 27 32 34 41 58 62 60 69 67 62
Tax % 5% 29% 101% 51% -60% 19% 25% 27% 26% 25% 21% 28%
30 27 -0 16 54 34 44 45 45 52 53 45
EPS in Rs 5.99 5.32 -0.07 2.79 9.55 5.14 6.66 6.87 6.80 7.86 7.99 6.84
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
463 486 733 893 1,070 1,262
379 419 580 691 831 965
Operating Profit 84 67 153 201 238 297
OPM % 18% 14% 21% 23% 22% 24%
0 4 4 8 26 29
Interest 26 39 44 42 26 11
Depreciation 26 31 36 39 42 57
Profit before tax 33 2 77 129 195 258
Tax % 10% 248% 34% 43% 10% 25%
30 -2 51 73 177 194
EPS in Rs 5.83 -0.45 10.05 12.90 26.94 29.47
Dividend Payout % 0% 0% 0% 0% 4% 3%
Compounded Sales Growth
10 Years: %
5 Years: 22%
3 Years: 20%
TTM: 18%
Compounded Profit Growth
10 Years: %
5 Years: 44%
3 Years: 56%
TTM: 9%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 20%
Return on Equity
10 Years: %
5 Years: 17%
3 Years: 19%
Last Year: 15%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 51 51 51 57 66 66
Reserves 186 188 243 309 1,103 1,291
272 426 495 469 0 393
94 124 120 151 112 155
Total Liabilities 603 789 909 986 1,281 1,905
435 630 684 720 718 977
CWIP 10 26 27 29 74 185
Investments 2 7 3 2 17 114
156 126 195 235 473 628
Total Assets 603 789 909 986 1,281 1,905

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
74 123 137 117 115 253
-43 -295 -84 -104 -76 -209
-32 184 32 18 128 301
Net Cash Flow -1 12 85 31 167 345

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 35 16 14 19 20 12
Inventory Days 64 48 39 44 41 38
Days Payable 268 217 157 164 120 163
Cash Conversion Cycle -169 -152 -104 -101 -59 -113
Working Capital Days 39 -4 -9 -17 -5 16
ROCE % 7% 17% 21% 22% 18%

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91%
4.62% 3.96% 4.17% 6.06% 8.84% 10.04% 10.04%
12.69% 13.92% 14.16% 13.85% 13.46% 15.75% 15.64%
41.80% 41.19% 40.76% 39.18% 36.79% 33.31% 33.43%
No. of Shareholders 54,78239,34835,10735,79734,08133,91433,956

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls